Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - Mark V . Dahl, M.D.

Back to Research Profile

  1. Odom R, Dahl M, Dover J, Draelos Z, Drake L, Macsai M, Powell F, Thiboutot D, Webster GF, Wilkin J. Standard management options for rosacea, part 2: options according to subtype. Cutis 2009 Aug; 84(2):97-104.
    View PubMed
  2. Odom R, Dahl M, Dover J, Draelos Z, Drake L, Macsai M, Powell F, Thiboutot D, Webster GF, Wilkin J. Standard management options for rosacea, part 1: overview and broad spectrum of care. Cutis 2009 Jul; 84(1):43-7.
    View PubMed
  3. Bamford JT, Gessert CE, Renier CM, Jackson MM, Laabs SB, Dahl MV, Rogers RS 3rd. Childhood stye and adult rosacea. J Am Acad Dermatol 2006 Dec; 55(6):951-5. Epub 2006 Sep 05.
    View PubMed
  4. Wetter DA, Davis MD, Yiannias JA, Gibson LE, Dahl MV, el-Azhary RA, Bruce AJ, Lookingbill DP, Ahmed I, Schroeter AL, Pittelkow MR. Effectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experience. Mayo Clin Proc 2005 Jan; 80(1):41-7.
    View PubMed
  5. Del Rosso JQ, Dahl MV, Draelos ZD, Jones D, Murphy G, Odom R, Powell FC. Classification, pathophysiology, and treatment of rosacea. Cutis 2004 Sep; 74(3 Suppl S):32-4.
  6. Dahl MV. Rosacea subtypes: a treatment algorithm. Cutis 2004 Sep; 74(3 Suppl):21-7, 32-4.
    View PubMed
  7. Dahl MV, Ross AJ, Schlievert PM. Temperature regulates bacterial protein production: Possible role in rosacea. J Am Acad Dermatol 2004 Feb; 50(2):266-72.
    View PubMed
  8. Kyle AA, Dahl MV. Topical therapy for fungal infections. Am J Clin Dermatol 2004; 5(6):443-51.
    View PubMed
  9. Wilkin J, Dahl MV, Detmar M, Drake L, Liang MH, Odom R, Powell F. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2004; 50:907-912.
    View PubMed
  10. Ahmed AR, Dahl MV. Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases. Arch Dermatol 2003 Aug; 139(8):1051-9.
    View PubMed
  11. Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, Powell F. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002 Apr; 46(4):584-7.
    View PubMed
  12. Dahl MV, Jarratt M, Kaplan D, Tuley MR, Baker MD. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol 2001 Nov; 45(5):723-730.
    View PubMed
  13. Dahl MV. Pathogenesis of rosacea. Adv Dermatol 2001; 17:29-45.
    View PubMed
  14. Ahmed I, Cronk JS, Crutchfield CE 3rd, Dahl MV. Myeloma-associated systemic amyloidosis presenting as chronic paronychia and palmodigital erythematous swelling and induration of the hands. J Am Acad Dermatol 2000 Feb; 42(2 Pt 2):339-42.
    View PubMed
  15. Pride HB, Winfield JA, Dahl MV, Papa CA. Camp Discovery: the second 3 years. J Am Acad Dermatol 1999; 41:1011-7.
    View PubMed
  16. Vu TN, Lee TX, Ndoye A, Shultz LD, Pittelkow MR, Dahl MV, Lynch PJ, Grando SA. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus. Arch Dermatol 1998 Aug; 134(8):971-80.
    View PubMed
  17. Dahl MV, Katz HI, Krueger GG, Millikan LE, Odom RB, Parker F, Wolf JE Jr, Aly R, Bayles C, Reusser B, Weidner M, Coleman E, Patrignelli R, Tuley MR, Baker MO, Herndon JH Jr, Czernielewski JM. Topical metronidazole maintains remissions of rosacea. Arch Dermatol 1998 Jun; 134(6):679-83.
    View PubMed
  18. Ikuta K, Shibata N, Blake JS, Dahl MV, Nelson RD, Hisamichi K, Kobayashi H, Suzuki S, Okawa Y. NMR study of the galactomannans of Trichophyton mentagrophytes and Trichophyton rubrum. Biochem J 1997 Apr 1; 323(Pt 1):297-305.
    View PubMed
  19. Grando SA, Horton RM, Mauro TM, Kist DA, Lee TX, Dahl MV. Activation of keratinocyte nicotinic cholinergic receptors stimulates calcium influx and enhances cell differentiation. J Invest Dermatol 1996 Sep; 107(3):412-8.
    View PubMed
  20. Dahl MV, Roering MJ, Pride HB, Rabinowitz LK. Camp Knutson: the first three years. J Am Acad Dermatol 1996 Jul; 35(1):96-100.
    View PubMed
  21. Grando SA, Zelickson BD, Kist DA, Weinshenker D, Bigliardi PL, Wendelschafer-Crabb G, Kennedy WR, Dahl MV. Keratinocyte muscarinic acetylcholine receptors: immunolocalization and partial characterization. J Invest Dermatol 1995 Jan; 104(1):95-100.
    View PubMed
  22. Dahl MV. Dermatophytosis and the immune response. J Am Acad Dermatol 1994 Sep; 31(3 Pt 2):S34-41.
    View PubMed
  23. MacCarthy KG, Blake JS, Johnson KL, Dahl MV, Kalish RS. Human dermatophyte-responsive T-cell lines recognize cross-reactive antigens associated with mannose-rich glycoproteins. Exp Dermatol 1994 Apr; 3(2):66-71.
    View PubMed
  24. Bigliardi PL, Herron MJ, Nelson RD, Dahl MV. Effects of detergents on proliferation and metabolism of human keratinocytes. Exp Dermatol 1994 Apr; 3(2):89-94.
    View PubMed
  25. Dahl MV. Clinical pearl: diascopy helps diagnose urticarial vasculitis. J Am Acad Dermatol 1994 Mar; 30(3):481-2.
    View PubMed
  26. Dahl MV, Grando SA. Chronic dermatophytosis: what is special about Trichophyton rubrum? Adv Dermatol 1994; 9:97-109, discussion 110-1.
    View PubMed
  27. Grando SA, Crosby AM, Zelickson BD, Dahl MV. Agarose gel keratinocyte outgrowth system as a model of skin re-epithelization: requirement of endogenous acetylcholine for outgrowth initiation. J Invest Dermatol 1993 Dec; 101(6):804-10.
    View PubMed
  28. Grando SA, Kist DA, Qi M, Dahl MV. Human keratinocytes synthesize, secrete, and degrade acetylcholine. J Invest Dermatol 1993 Jul; 101(1):32-6.
    View PubMed
  29. Dahl MV. Suppression of immunity and inflammation by products produced by dermatophytes. J Am Acad Dermatol 1993 May; 28(5 Pt 1):S19-S23.
    View PubMed
  30. Beers B, Kalish RS, Kaye VN, Dahl MV. Unilateral linear lichenoid eruption after bone marrow transplantation: an unmasking of tolerance to an abnormal keratinocyte clone? J Am Acad Dermatol 1993 May; 28(5 Pt 2):888-92.
    View PubMed
  31. Cabrera R, Agar A, Dahl MV. The immunology of scabies. Semin Dermatol 1993 Mar; 12(1):15-21.
    View PubMed
  32. Grando SA, Cabrera R, Hostager BS, Bigliardi PL, Blake JS, Herron MJ, Dahl MV, Nelson RD. Computerized microassay of keratinocyte cell-plastic attachment and proliferation for assessing net stimulatory, inhibitory and toxic effects of compounds on nonimmortalized cell lines. Skin Pharmacol 1993; 6(2):135-47.
    View PubMed
  33. Grando SA, Dahl MV. Activation of keratinocyte muscarinic receptors reverses pemphigus acantholysis. J Eur Acad Dermatol Venereol 1993; 2:72-86.
  34. Grando SA, Herron MJ, Dahl MV, Nelson RD. Binding and uptake of Trichophyton rubrum mannan by human epidermal keratinocytes: a time-course study. Acta Derm Venereol 1992 Aug; 72(4):273-6.
    View PubMed
  35. Grando SA, Hostager BS, Herron MJ, Dahl MV, Nelson RD. Binding of Trichophyton rubrum mannan to human monocytes in vitro. J Invest Dermatol 1992 Jun; 98(6):876-80.
    View PubMed
  36. Ward JC, Gitlin JB, Garry DJ, Jatoi A, Luikart SD, Zelickson BD, Dahl MV, Skubitz KM. Epidermolysis bullosa acquisita induced by GM-CSF: a role for eosinophils in treatment-related toxicity. Br J Haematol 1992 May; 81(1):27-32.
    View PubMed
  37. Booth SA, Moody CE, Dahl MV, Herron MJ, Nelson RD. Dapsone suppresses integrin-mediated neutrophil adherence function. J Invest Dermatol 1992 Feb; 98(2):135-40.
    View PubMed
  38. Blake JS, Dahl MV, Herron MJ, Nelson RD. An immunoinhibitory cell wall glycoprotein (mannan) from Trichophyton rubrum. J Invest Dermatol 1991 May; 96(5):657-61.
    View PubMed
  39. Swanson DL, Dahl MV. Embolic abscesses in hereditary hemorrhagic telangiectasia. J Am Acad Dermatol 1991 Apr; 24(4):580-3.
    View PubMed
  40. Dahl MV. Flare factors and atopic dermatitis: the role of allergy. J Dermatol Sci 1990 Sep; 1(5):311-8.
    View PubMed
  41. Bernstein JE, Korman NJ, Bickers DR, Dahl MV, Millikan LE. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol 1989 Aug; 21(2 Pt 1):265-70.
    View PubMed
  42. Scheman AJ, Ray DJ, Witkop CJ Jr, Dahl MV. Hereditary mucoepithelial dysplasia. Case report and review of the literature. J Am Acad Dermatol 1989 Aug; 21(2 Pt 2):351-7.
    View PubMed
  43. MacCarthy KG, Dahl MV. Inhibition of growth of Trichophyton rubrum by the myeloperoxidase-hydrogen peroxide-chloride system. J Invest Dermatol 1989 Apr; 92(4):639-41.
    View PubMed
  44. Dahl MV. Insect bite reactions. Immunol Allergy Clin North Am 1989; 9:555-562.
  45. Dahl MV. Immunofluorescence, necrobiosis lipoidica, and blood vessels. Fluorescent lights in the tunnels. Arch Dermatol 1988 Sep; 124(9):1417-9.
    View PubMed
  46. Dahl MV. Chronic, irritant contact dermatitis: mechanisms, variables, and differentiation from other forms of contact dermatitis. Adv Dermatol 1988; 3:261-75.
    View PubMed
  47. Bernstein JE, Bickers DR, Dahl MV, Roshal JY. Treatment of chronic postherpetic neuralgia with topical capsaicin. A preliminary study. J Am Acad Dermatol 1987 Jul; 17(1):93-6.
    View PubMed
  48. Fanselow D, Crone M, Dahl MV. Dosimetry in phototherapy cabinets. J Am Acad Dermatol 1987 Jul; 17(1):74-7.
    View PubMed
  49. Dahl MV. Strategies for the management of recurrent furunculosis. South Med J 1987 Mar; 80(3):352-6.
    View PubMed
  50. Dahl MV. Bullous pemphigoid: associated diseases. Clin Dermatol 1987 Jan-Mar; 5(1):64-70.
    View PubMed
  51. Dahl MV. Immunological resistance to dermatophyte infections. Adv Dermatol 1987; 2:305-20.
    View PubMed
  52. Dahl MV. Host defense against dermatophytes. Adv Dermatol 1987; 2:305-320.
    View PubMed
  53. Roenigk RK, Dahl MV. Bullous pemphigoid and prurigo nodularis. J Am Acad Dermatol 1986 May; 14(5 Pt 2):944-7.
    View PubMed
  54. Dahl MV, Carpenter R. Polymorphonuclear leukocytes, complement, and Trichophyton rubrum. J Invest Dermatol 1986 Feb; 86(2):138-41.
    View PubMed
  55. Dahl MV. Immunoglobulin deposition in skin of patients with lupus erythematosus: clinical correlates and indications for direct immunofluorescence. Adv Dermatol 1986; 1:247-66.
    View PubMed
  56. Blaszczyk M, Chorzelski T, Dahl MV, Wartos C, Klinczna TZW. Lupus band test. Przeg. derm 1986; 72:219-224.
  57. Dahl MV. Acquired subepidermal bullous diseases. Australas J Dermatol 1985 Dec; 26(3):93-7.
    View PubMed
  58. Dahl MV. Resistance factors in dermatophyte infections. Australas J Dermatol 1985 Dec; 26(3):98-101.
    View PubMed
  59. Dahl MV. Speculations on the pathogenesis of granuloma annulare. Australas J Dermatol 1985 Aug; 26(2):49-57.
    View PubMed
  60. Padilla RS, Holguin T, Burgdorf WH, Dahl MV. Serum lysozyme in patients with localized and generalized granuloma annulare. Arch Dermatol 1985 May; 121(5):624-5.
    View PubMed
  61. Dahl MV, Falk RJ, Carpenter R, Michael AF. Membrane attack complex of complement in dermatitis herpetiformis. Arch Dermatol 1985 Jan; 121(1):70-2.
    View PubMed
  62. Beutner EH, Chorzelski TP, Jablonska S, Dahl MV, et al. Immunofluorescent tests: clinical significance of sera and skin in bullous diseases. Int J Dermatol 1985; 24:405-421.
    View PubMed
  63. Dahl MV, Swanson DL, Jacob HS. A dermatitis-eosinophilia syndrome. Treatment with methylprednisolone pulse therapy. Arch Dermatol 1984 Dec; 120(12):1595-7.
    View PubMed
  64. Dahl MV, Pass F, Trancik RJ. Sodium lauryl sulfate irritant patch tests. II. Variations of test responses among subjects and comparison to variations of allergic responses elicited by Toxicodendron extract. J Am Acad Dermatol 1984 Sep; 11(3):474-7.
    View PubMed
  65. Dahl MV, Roering MJ. Sodium lauryl sulfate irritant patch tests. III. Evaporation of aqueous vehicle influences inflammatory response. J Am Acad Dermatol 1984 Sep; 11(3):477-9.
    View PubMed
  66. Dahl MV, Pass F, Trancik RJ. Toxicodendron antigen patch test. Degrees of inflammation observed after various time intervals. Arch Dermatol 1984 Aug; 120(8):1022-4.
    View PubMed
  67. Dahl MV, Falk RJ, Carpenter R, Michael AF. Deposition of the membrane attack complex of complement in bullous pemphigoid. J Invest Dermatol 1984 Feb; 82(2):132-5.
    View PubMed
  68. Dahl MV. Pitfals of patch testing. Curr Issues Dermatol 1984; 2:255-68.
  69. Dahl MV. The immunology of scabies. Ann Allergy 1983 Dec; 51(6):560-6.
    View PubMed
  70. Dahl MV. Usefulness of direct immunofluorescence in patients with lupus erythematosus. Arch Dermatol 1983 Dec; 119(12):1010-7.
    View PubMed
  71. Fanselow DL, Pathak MA, Crone MA, Ersfeld DA, Raber PB, Trancik RJ, Dahl MV. Reusable ultraviolet monitors: design, characteristics, and efficacy. J Am Acad Dermatol 1983 Nov; 9(5):714-23.
    View PubMed
  72. Dahl MV. Staphylococcus aureus and atopic dermatitis. Arch Dermatol 1983 Oct; 119(10):840-6.
    View PubMed
  73. Swanson DL, Dahl MV. Methylprednisolone inhibits pemphigus acantholysis in skin cultures. J Invest Dermatol 1983 Sep; 81(3):258-60.
    View PubMed
  74. Katz HI, Hien NT, Prawer SE, Goltz RW, Manick KP, Dahl MV, Briden ME. A three-dimensional photography system for dermatologic diagnosis. J Am Acad Dermatol 1983 Jun; 8(6):850-6.
    View PubMed
  75. Padilla RS, Mukai K, Dahl MV, Burgdorf WH, Rosai J. Differential staining pattern of lysozyme in palisading granulomas: an immunoperoxidase study. J Am Acad Dermatol 1983 May; 8(5):634-8.
    View PubMed
  76. Dahl MV. Some aspects of atopic dermatitis. Arch Dermatol 1983 Mar; 119(3):237-42.
    View PubMed
  77. Swan JW, Dahl MV, Coppo PA, Hammerschmidt DE. Complement activation by trichophyton rubrum. J Invest Dermatol 1983 Mar; 80(3):156-8.
    View PubMed
  78. Dahl MV, Dahl AC. 12% lactate lotion for the treatment of xerosis. A double-blind clinical evaluation. Arch Dermatol 1983 Jan; 119(1):27-30.
    View PubMed
  79. Dahl MV. The evaluation of neutrophil function. Curr Issues Dermatol 1983; 1:153-70.
  80. Michaud RM, Jacobson D, Dahl MV. Papular dermatitis of pregnancy. Arch Dermatol 1982 Dec; 118(12):1003-5.
    View PubMed
  81. Abramson JS, Dahl MV, Walsh G, Blumenthal MN, Douglas SD, Quie PG. Antistaphylococcal IgE in patients with atopic dermatitis. J Am Acad Dermatol 1982 Jul; 7(1):105-10.
    View PubMed
  82. Peterson PK, Dahl MV, Howard RJ, Simmons RL, Najarian JS. Mucormycosis and cutaneous histoplasmosis in a renal transplant recipient. Arch Dermatol 1982 Apr; 118(4):275-7.
    View PubMed
  83. Flynn KJ, Dehner LP, Gajl-Peczalska KJ, Dahl MV, Ramsay N, Wang N. Regressing atypical histiocytosis: a cutaneous proliferation of atypical neoplastic histiocytes with unexpectedly indolent biologic behavior. Cancer 1982 Mar 1; 49(5):959-70.
    View PubMed
  84. Flynn KJ, Dehner LP, Gajl-Peczalska KJ, Dahl MV, Ramsay N, Wang N. Regressing atypical histiocytosis: benign or malignant? Minn Med 1982 Feb; 65(2):73-6.
    View PubMed
  85. Abramson JS, Dahl MV, Walsh G, Blumenthal MN, Douglas SD, Quie PG. Antistaphylococcal IgE in patients with eczema, hyperimmunoglobulinemia E, and recurrent infections. J Am Acad Dermatol 1982; 7:105-110.
    View PubMed
  86. Swanson DL, Dahl MV. Pemphigus vulgaris and plasma exchange: clinical and serologic studies. J Am Acad Dermatol 1981 Mar; 4(3):325-8.
    View PubMed
  87. Britt WJ, Duray PH, Dahl MV, Goltz RW. Diffuse fasciitis with eosinophilia: a steroid-responsive variant of scleroderma. J Pediatr 1980 Sep; 97(3):432-4.
    View PubMed
  88. Fisher I, Dahl MV, Christiansen TA. Cicatricial pemphigoid confined to the larynx. Cutis 1980 Apr; 25(4):371-3.
    View PubMed
  89. Dahl MV, Cherney KJ, Lindroos WE. Elevated heparin-precipitable fraction of plasma in granuloma annulare. Arch Dermatol 1979 Sep; 115(9):1059-60.
    View PubMed
  90. Cherney KJ, Lindroos WE, Goltz RW, Dahl MV. Leukocyte function in granuloma annulare. Br J Dermatol 1979 Jul; 101(1):23-31.
    View PubMed
  91. Witkop CJ Jr, White JG, King RA, Dahl MV, Young WG, Sauk JJ Jr. Hereditary mucoepithelial dysplasia: a disease apparently of desmosome and gap junction formation. Am J Hum Genet 1979 Jul; 31(4):414-27.
    View PubMed
  92. Buselmeier TJ, Cantieri JS, Dahl MV, Nelson RS, Baumgaertner JC, Bentley CR, Goltz RW. Clearing of psoriasis after cardiac surgery requiring cardiopulmonary bypass oxygenation: a corollary to clearance after dialysis? Br J Dermatol 1979 Mar; 100(3):311-3.
    View PubMed
  93. McKeever PJ, Dahl MV. Subcorneal pustular dermatosis. Vet Clin North Am 1979 Feb; 9(1):73-7.
    View PubMed
  94. Dahl MV, Lindroos WE. Leukocyte chemotaxis under agarose: manipulations of serum and plasma before incorporation into agarose can influence cell movement. J Immunol Methods 1979; 29(4):301-10.
    View PubMed
  95. Dahl MV, Lindroos WE, Nelson RD. Chemokinetic and chemotactic factors in psoriasis scale extracts. J Invest Dermatol 1978 Dec; 71(6):402-6.
    View PubMed
  96. Buselmeier TJ, Dahl MV, Kjellstrand CM, Goltz RW. Dialysis therapy for psoriasis. JAMA 1978 Sep 15; 240(12):1270.
    View PubMed
  97. Dahl MV, Ristow S. Bullous pemphigoid and ovarian cystadenocarcinoma. Immunologic studies. Arch Dermatol 1978 Jun; 114(6):903-5.
    View PubMed
  98. Dahl MV, Cates KL, Quie PG. Neutrophil chemotaxis in patients with atopic dermatitis without infection. Arch Dermatol 1978 Apr; 114(4):544-6.
    View PubMed
  99. Dahl MV. Chemotaxis in cutaneous disease. Int J Dermatol 1978 Mar; 17(2):95-104.
    View PubMed
  100. Dahl MV. Primary immunodeficiency diseases: evaluation and cutaneous manifestations. J Cont Educ Derm 1978; 17:31-45.
  101. Dahl MV. Familial endocrinopathy syndrome. J Cont Educ Derm 1978; 17:28-30.
  102. Buselmeier TJ, Kjellstrand CM, Dahl MV, Cantieri JS, Nelson RS, Burgdorf WC, Bentley CR, Najarian JS, Goltz RW. Treatment of psoriasis with dialysis. Proceedings of the European Dialysis & Transplant Association 1978; 15:171-7.
  103. Dahl MV, Trancik RJ. Sodium lauryl sulfate irritant patch tests: Degree of inflammation at various times. Contact Dermatitis 1978; 3:263-266.
  104. Ullman S, Dahl MV. Necrobiosis lipoidica. An immunofluorescence study. Arch Dermatol 1977 Dec; 113(12):1671-3.
    View PubMed
  105. Dahl MV, Trancik RJ. Sodium lauryl sulfate irritant patch tests: degree of inflammation at various times. Contact Dermatitis 1977 Oct; 3(5):263-6.
    View PubMed
  106. Nelson CE, Dahl MV, Goltz RW. Arcuate dermal erythema in a carrier of chronic granulomatous disease. Arch Dermatol 1977 Jun; 113(6):798-800.
    View PubMed
  107. McKeever PJ, Dahl MV. A disease in dogs resembling human subcorneal pustular dermatosis. J Am Vet Med Assoc 1977 Apr 1; 170(7):704-8.
    View PubMed
  108. Dahl MV, Ullman S, Goltz RW. Vasculitis in granuloma annulare: histopathology and direct immunofluorescence. Arch Dermatol 1977 Apr; 113(4):463-7.
    View PubMed
  109. Dahl MV. Atopic dermatitis: the concept of flare factors. South Med J 1977 Apr; 70(4):453-5.
    View PubMed
  110. Dahl MV. Erythema multiforme. Mod Med 1977; 45:42-46.
  111. Dahl MV, Greene WH Jr, Quie PG. Infection, dermatitis, increased IgE, and impaired neutrophil chemotaxis. A possible relationship. Arch Dermatol 1976 Oct; 112(10):1387-90.
    View PubMed
  112. Dahl MV. Dermatologic manifestations of immunodeficiency diseases. Prog Dermatol 1976; 10:9-12.
  113. Dahl MV, Matula G, Leonards R, Tuffanelli DL. Incontinentia pigmenti and defective neutrophil chemotaxis. Arch Dermatol 1975 Dec; 111(12):1603-5.
    View PubMed
  114. Dahl MV. Allergic contact dermatitis from footwear. Shoe dermatitis in 42 patients. Minn Med 1975 Dec; 58(12):871-4.
    View PubMed
  115. Elias PM, Fritsch P, Dahl MV, Wolff K. Staphylococcal toxic epidermal necrolysis: pathogenesis and studies on the subcellular site of action of exfoliatin. J Invest Dermatol 1975 Dec; 65(6):501-12.
    View PubMed
  116. Dahl MV. Mycosis fungoides. Clinical features of 22 patients. Minn Med 1975 Apr; 58(4):301-4.
    View PubMed
  117. Ullman S, Dahl MV. Direct immunofluorescence in oral pathology. Northwest Dent 1975 Jan-Feb; 54(1):16-20.
    View PubMed
  118. Jablonska S, Beutner EH, Dahl MV, et al. Uses for immunofluorescence tests of skin and sera: Utilization of immunofluorescence in the diagnosis of bullous diseases, lupus erythematosus, and certain other dermatoses. Arch Dermatol 1975; 111:371-381.
    View PubMed
  119. Jablonska S, Beutner EH, Dahl MV, et al. Uses for immunofluorescence tests of skin and sera: Utilization of immunofluorescence in the diagnosis of bullous diseases, lupus erythematosus, and certain other dermatoses. Int J Dermatol 1975; 14:83-100.
    View PubMed
  120. Dahl MV, McGowen JH, Katz SI, Vineyard WR. Pemphigus-like antibodies in sera of patients with thermal burns, gunshot wounds, and skin grafts. Mil Med 1974 Mar; 139(3):196-8.
    View PubMed
  121. Dahl MV, Katz SI, Scott RM, Binn LN. Viral studies in pemphigus. J Invest Dermatol 1974 Feb; 62(2):96-9.
    View PubMed
  122. Katz SI, Dahl MV, Penneys N, Trapani RJ, Rogentine N. HL-A antigens in pemphigus. Arch Dermatol 1973 Jul; 108(1):53-5.
    View PubMed
  123. Pedro SD, Dahl MV. Direct immunofluorescence of bullous systemic lupus erythematosus. Arch Dermatol 1973 Jan; 107(1):118-20.
    View PubMed
  124. Katz SI, Falchuk ZM, Dahl MV, Rogentine GN, Strober W. HL-A8: a genetic link between dermatitis herpetiformis and gluten-sensitive enteropathy. J Clin Invest 1972 Nov; 51(11):2977-80.
    View PubMed
  125. Dahl MV. Tetanus in Minnesota. Minn Med 1972 Sep; 55(9):787-91.
    View PubMed
  126. Jordon WP Jr, Dahl MV. Contact dermatitis from cellulose ester plastics. Arch Dermatol 1972 Jun; 105(6):880-5.
    View PubMed
  127. Jordan WP Jr, Dahl M, Albert HL. Contact dermatitis from glutaraldehyde. Arch Dermatol 1972 Jan; 105(1):94-5.
    View PubMed
  128. Jordan WP Jr, Dahl MV. Contact dermatitis to a plastic solvent in eyeglasses. Cross-sensitivity to ethyl acetate. Arch Dermatol 1971 Nov; 104(5):524-8.
    View PubMed
  129. Dahl MV, Jordan WP, Albert HA. Dermatitis from glutaraldehyde. J Am Dent Assoc 1971; 83:1183-1189.
    View PubMed
  130. Dahl MV. Emphysema. Arch Dermatol 1970 Jan; 101(1):117.
    View PubMed


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.